Monday June 26th 2017

Archive for September, 2011

Senator Cordy moves second reading of a Bill to establish a National Strategy for CCSVI

Senator Cordy moves second reading of a Bill to establish a National Strategy for CCSVI

Today Senator Jane Cordy moved second reading in the Senate of Bill S-204, An Act to Establish a National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) in MS patients. “Studies are beginning to show that improving blood flow through an angioplasty [Read More]

Science and politics clash in MS trials

Science and politics clash in MS trials

Scientific research and politics are always a bad combination, but that shouldn’t necessarily be taken as complete condemnation of the Saskatchewan Party government’s latest move on the multiple sclerosis front. There is obviously some merit to the provincial [Read More]

Cobourg native seeks liberation treatment for MS

Cobourg native seeks liberation treatment for MS

A former Cobourg resident hopes a controversial surgery, known as the liberation treatment, will help keep her out of a wheelchair. Born and raised in Cobourg, Rachel MacCulloch was diagnosed with relapsing/remitting Multiple Sclerosis (MS) in 1998 when she was 23 years [Read More]

 Page 1 of 5  1  2  3  4  5 »

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]